IRIS - Res&Arch Institutional Research Information System - Research & Archive

FANELLI, Carmine Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.467
EU - Europa 3.728
AS - Asia 2.915
SA - Sud America 494
AF - Africa 54
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 6
Totale 11.688
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.381
SG - Singapore 1.502
IE - Irlanda 594
UA - Ucraina 583
SE - Svezia 527
IT - Italia 499
CN - Cina 459
BR - Brasile 444
RU - Federazione Russa 425
HK - Hong Kong 381
DE - Germania 336
VN - Vietnam 239
FI - Finlandia 220
FR - Francia 157
GB - Regno Unito 132
KR - Corea 95
AT - Austria 51
TR - Turchia 51
PL - Polonia 49
CA - Canada 43
JP - Giappone 31
IN - India 30
NL - Olanda 30
MX - Messico 26
ES - Italia 24
ZA - Sudafrica 21
AR - Argentina 20
AU - Australia 20
CH - Svizzera 20
CZ - Repubblica Ceca 17
IQ - Iraq 17
UZ - Uzbekistan 17
BD - Bangladesh 15
BE - Belgio 14
GR - Grecia 12
JO - Giordania 11
ID - Indonesia 10
EC - Ecuador 8
LB - Libano 8
LT - Lituania 8
MA - Marocco 6
RO - Romania 6
KE - Kenya 5
NP - Nepal 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
IL - Israele 4
PH - Filippine 4
PK - Pakistan 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
CI - Costa d'Avorio 3
CL - Cile 3
CO - Colombia 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EE - Estonia 3
EG - Egitto 3
EU - Europa 3
KZ - Kazakistan 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
TN - Tunisia 3
TW - Taiwan 3
VE - Venezuela 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
GH - Ghana 2
HN - Honduras 2
HR - Croazia 2
IM - Isola di Man 2
KG - Kirghizistan 2
NG - Nigeria 2
PS - Palestinian Territory 2
RS - Serbia 2
TH - Thailandia 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
ET - Etiopia 1
GD - Grenada 1
GY - Guiana 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
LC - Santa Lucia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 11.679
Salva come PNG Salva come JPEG
Città #
Singapore 975
Chandler 684
Dublin 594
Hong Kong 376
San Mateo 346
Boardman 274
Jacksonville 270
Ashburn 214
Santa Clara 196
Altamura 192
Medford 171
Princeton 169
Wilmington 144
Lawrence 129
Perugia 119
Munich 117
Beijing 115
Moscow 108
Seoul 93
Ann Arbor 88
Des Moines 86
New York 86
Dong Ket 85
Andover 78
Los Angeles 78
Helsinki 73
Saint Petersburg 53
Ho Chi Minh City 49
São Paulo 43
Piscataway 39
Brooklyn 35
Falls Church 35
Frankfurt am Main 33
Rome 33
Hanoi 32
Warsaw 30
Chicago 28
Izmir 28
Woodbridge 27
Tokyo 26
Norwalk 25
Nuremberg 24
Stockholm 24
Vienna 22
Turku 20
Dallas 18
Fremont 16
London 16
San Francisco 16
Amelia 15
Amsterdam 15
Milan 15
San Paolo di Civitate 15
Falkenstein 14
Montreal 14
Redmond 14
Rio de Janeiro 14
Ankara 13
Brussels 13
Denver 12
Orem 12
Amman 11
Atlanta 11
Brno 11
Auburn Hills 10
Boston 10
Johannesburg 10
Mexico City 10
Poplar 10
Shanghai 10
The Dalles 10
Houston 9
Porto Alegre 9
Roubaix 9
Tashkent 9
Belo Horizonte 8
Bolton 8
Campinas 8
Chennai 8
Curitiba 8
Goiânia 8
Haiphong 8
Toronto 8
Bexley 7
Brasília 7
Columbus 7
Cáceres 7
Guangzhou 7
Melbourne 7
Phoenix 7
Redwood City 7
Athens 6
Baghdad 6
Birmingham 6
Changsha 6
Den Haag 6
Frankfurt Am Main 6
Istanbul 6
Mumbai 6
Renton 6
Totale 7.011
Salva come PNG Salva come JPEG
Nome #
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules. 151
Adrenaline vs glucagon in the primacy of glucose counterregulation 151
Different brain responses to hypoglycemia induced by equipotent doses of long-acting insulin analog detemir and human regular insulin in humans 139
Hypoglycemia 132
Administration of neutral protamine Hagerdon insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial. 130
An intensive lifestyle intervention in children with attention-deficit/hyperactivity disorder 123
18. Insulin required for prandial ghrelin suppression in humans 115
Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes 113
Physical activity habits and well-being among 6-year-old children: The “improving umbrian kids’ healthy lifestyle”, an uncontrolled pilot study project 111
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia. 109
Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans. 106
Effects of an Intensive Lifestyle Intervention to Treat Overweight/Obese Children and Adolescents 105
Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia 104
Adrenergic mechanisms do not contribute to glucose counterregulation during acute insulin-induced hypoglycaemia in normal man. 103
Cognitive function in hypoglycaemia 101
Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans. 101
Administration of Neutral Protamine Hagedorn insulin at bedtime versus dinner in Type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control: a randomized, controlled trial. 101
Comparison of pharmacokinetics and-dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes mellitus: a double-blind, randomized, cross-over study. 100
A novel surrogate index for hepatic insulin resistance. 99
Insulin is required for prandial ghrelin suppression in humans 98
Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs 97
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules. 97
Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes mellitus. 96
Uso dell’analogo ad azione rapida lispro con l’analogo ad azione ritardo glargine nel trattamento intensivo del T1DM 95
Intensive lifestyle intervention is particularly advantageous in poorly controlled type 2 diabetes 95
IMPACT OF NOCTURNAL HYPOGLYCEMIA ON HYPOGLYCEMIC COGNITIVE DYSFUNCTION IN TYPE 1 DIABETES 93
Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans 92
Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis 92
Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study. 90
Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. 90
Physical activity level and mediterranean diet adherence evaluation in older people - observational, uncontrolled, pilot study 90
Early improvement of glucose tolerance after ileal transposition in a nonobese Type 2 diabetes rat model. 89
Pharmacokinetics and pharmacodynamic of therapeutic dose of basel insulins NPH, Glargine and Detemir after one week of daily administration at bedtime in Type 2 daibates: a randomized, cross-over study. 89
Nocturnal blood glucose control in type I diabetes mellitus. 89
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules 88
Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting analogue at mealtime. A three month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime. 86
Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. 86
Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study. 86
Counterregulatory hormone and symptom responses to insulin-induced hypoglycaemia in the postprandial state in humans 84
Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. 84
Are three months multidisciplinary lifestyle intervention enough to get benefits on blood pressure in overweight/obese adults ? 84
The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity 82
Pivotal role of timely basal insulin replacement after metformin failure in sustaining long-term blood glucose control at a target in Type 2 diabetes. 82
Effects of a supervised nordic walking program on obese adults with and without type 2 diabetes: The C.U.R.I.A.Mo. Centre experience 82
Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes 79
Evaluation of maximum oxygen consumption in obese adolescents before and after a multidisciplinary lifestyle intervention 78
Intensive replacement of basal insulin in patients with Type 1 diabetes mellitus given rapid-acting insulin analogue at meal-time: a three-month comparison between administration of NPH four times daily and glargine insulin at dinner or bedtime. 77
Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia 77
Glucagon: the effects of its excess and deficiency on insulin action 77
PHARMACOKINETIC AND PHARMACODYNAMIC HEAD-TO-HEAD COMPARISON OF CLINICAL, EQUIVALENT DOSES OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC 100 U/ML IN TYPE 1 DIABETES 77
Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced hypoglycaemia in humans. 76
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. 76
Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes. 75
Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. 75
Hyperglycemia, Both Chronic and in Short-Term Peaks, Results in Rapid Increase of Expression of Monocyte Inducible Cyclooxygenase (COX-2) in Subjects with T2DM 75
Premeal Insulin Treatment During Basal-Bolus Regimen in Young Children With Type 1 Diabetes 75
Effect of Short Term Intensive Lifestyle Intervention on Hepatic Steatosis Indexes in Adults with Obesity and/or Type 2 Diabetes 74
Ipoglicemia: cause e prevenzione 73
Body composition and common carotid artery remodeling in a healthy population 73
Ricoveri per ipoglicemia grave in soggetti con diabete mellito di tipo 2: impatto clinico e costi sanitari 73
Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus. 72
Influence of Apolipoproteins on the Association Between Lipids and Insulin Sensitivity: A cross-sectional analysis of the RISC Study 72
Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humans. 71
Circulatin ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement 71
Pharmacokinetics, pharmacodynamics, and modulation of hepatic glucose production with insulin glargine U300 and glargine U100 at steady state with individualized clinical doses in type 1 diabetes 71
Impact of BMI, Physical Activity, and Sitting Time Levels on Health-Related Outcomes in a Group of Overweight and Obese Adults with and without Type 2 Diabetes 71
Counterregulatory responses in CSII 70
Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people. 70
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro 70
Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus 68
Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin 68
Is physical activity a necessary element during Italian coronavirus disease emergency? Yes or no debate 68
Impact of recent antecedent hypoglycemia on hypoglycemic cognitive dysfunction in nondiabetic humans. 67
L’ipoglicemia silente nella pratica clinica quotidiana: come diagnosticarla, gestirla e prevenirla 67
Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis. 66
Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes. 66
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes. 66
Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement 66
A multistep approach for the stratification of the risk of severe hypoglycemia in patients with type 2 diabetes 66
Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. 65
Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: A dose–response study 65
Quando “i conti non tornano” (Caso clinico) G It Diabetol Metab 26:172-175 64
Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus 64
Female Sex and Angiotensin-Converting Enzyme (ACE) Insertion/Deletion Polymorphism Amplify the Effects of Adiposity on Blood Pressure 64
Nutritional Management of Athletes with Type 1 Diabetes: A Narrative Review 63
Shift of glycaemic thresholds for cognitive function in hypoglycaemia unawareness in humans. 63
Pharmacokinetics and pharmacodynamics of NPH insulin in type 1 diabetes: The Importance of appropriate resuspension before subcutaneous injection 63
Responses to hypoglycemia in diabetic autonomic neuropathy. 63
Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus 63
Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement. 62
Insulin therapy and hypoglycemia: the size of the problem 61
One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort 61
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. 59
Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women. 59
Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM. 59
Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study. 59
"Strength gains in different age groups of overweight/obese adults: A pilot uncontrolled study" 58
La terapia insulinica nel diabete mellito tipo 2. 58
Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes. 58
Obesity and carotid artery remodeling 58
Totale 8.235
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.879
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.879
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021658 0 0 0 0 0 115 78 15 172 58 103 117
2021/20221.282 29 233 30 83 34 20 20 407 16 32 137 241
2022/20232.310 184 465 31 191 170 287 5 95 788 3 67 24
2023/2024982 54 105 43 33 8 8 195 14 77 39 185 221
2024/20252.340 36 230 81 126 366 65 59 182 513 167 304 211
2025/20262.646 360 325 266 603 779 313 0 0 0 0 0 0
Totale 12.001